Cargando…
17‐β‐estradiol reduces surface PD‐L1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345460/ https://www.ncbi.nlm.nih.gov/pubmed/37448208 http://dx.doi.org/10.1002/ctm2.1330 |
| _version_ | 1785073093284200448 |
|---|---|
| author | Li, Hongzhuo Gu, Wenyi Jeffery, Penny Chen, Chen |
| author_facet | Li, Hongzhuo Gu, Wenyi Jeffery, Penny Chen, Chen |
| author_sort | Li, Hongzhuo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10345460 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103454602023-07-15 17‐β‐estradiol reduces surface PD‐L1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells Li, Hongzhuo Gu, Wenyi Jeffery, Penny Chen, Chen Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2023-07-13 /pmc/articles/PMC10345460/ /pubmed/37448208 http://dx.doi.org/10.1002/ctm2.1330 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Li, Hongzhuo Gu, Wenyi Jeffery, Penny Chen, Chen 17‐β‐estradiol reduces surface PD‐L1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells |
| title | 17‐β‐estradiol reduces surface PD‐L1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells |
| title_full | 17‐β‐estradiol reduces surface PD‐L1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells |
| title_fullStr | 17‐β‐estradiol reduces surface PD‐L1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells |
| title_full_unstemmed | 17‐β‐estradiol reduces surface PD‐L1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells |
| title_short | 17‐β‐estradiol reduces surface PD‐L1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells |
| title_sort | 17‐β‐estradiol reduces surface pd‐l1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345460/ https://www.ncbi.nlm.nih.gov/pubmed/37448208 http://dx.doi.org/10.1002/ctm2.1330 |
| work_keys_str_mv | AT lihongzhuo 17bestradiolreducessurfacepdl1expressioninestrogenreceptorpositivebreastcancerbutnottype1endometrialcancercells AT guwenyi 17bestradiolreducessurfacepdl1expressioninestrogenreceptorpositivebreastcancerbutnottype1endometrialcancercells AT jefferypenny 17bestradiolreducessurfacepdl1expressioninestrogenreceptorpositivebreastcancerbutnottype1endometrialcancercells AT chenchen 17bestradiolreducessurfacepdl1expressioninestrogenreceptorpositivebreastcancerbutnottype1endometrialcancercells |